title: Expression of beta 2-integrins and L-selectin on polymorphonuclear leukocytes in septic patients.
abstract: Adhesion molecules on polymorphonuclear leukocytes (PMNL) play an important role in nonspecific defense mechanisms directed at invading microorganisms. When local infection, however, cannot be controlled, a systemic inflammatory response syndrome (SIRS) ensues which may progress to septic shock and multiple organ failure, these being major determinants of the patient's outcome. In the present study, the expression of beta 2-integrins and L-selectin on blood PMNL was measured on subsequent days in patients with sepsis (n = 17) and in healthy volunteers (n = 15). beta 2-Integrins and L-selectin molecules were detected by flow cytometry, using the monoclonal antibodies IB4 (anti-CD18) and Dreg200 (anti-CD62L), respectively. Adhesion molecules were determined at baseline immediately after blood collection and also 45 min after incubation of cells in vitro at body temperature to allow for spontaneous regulation. In addition, PMNL were activated by receptor-dependent and receptor-independent stimuli to characterize stimulus-specific adhesion molecule expression. In parallel with the measurement of adhesion molecules, severity of sepsis was assessed by the Elebute score. The results demonstrate significant differences in the basal, spontaneous and stimulus-induced expression of adhesion molecules between healthy volunteers, survivors (n = 11) and nonsurvivors (n = 6). Moreover, when survivors and nonsurvivors with severe sepsis (Elebute score > 12) were compared, basal expressions of both beta 2-integrins and L-selectin were significantly lower in patients who did not survive. Thus, measurement of adhesion molecules on circulating PMNL may be useful to identify septic patients at high risk for lethal outcome.
authors.affiliation: Department of Anaesthesiology, University of Munich, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Thiel
authors.forename: C
authors.initials: C
authors.lastname: Zourelidis
authors.forename: J D
authors.initials: JD
authors.lastname: Chambers
authors.forename: U H
authors.initials: UH
authors.lastname: von Andrian
authors.forename: K E
authors.initials: KE
authors.lastname: Arfors
authors.forename: K
authors.initials: K
authors.lastname: Messmer
authors.forename: K
authors.initials: K
authors.lastname: Peter
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018821:CD18 Antigens / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D005260:Female; D006801:Humans; D019041:L-Selectin / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000378:metabolism*; D018805:Sepsis / Q000378:metabolism*; D012720:Severity of Illness Index; D017741:Survivors; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D018821:CD18 Antigens; D014409:Tumor Necrosis Factor-alpha; D019041:L-Selectin; D000001:Calcimycin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D013755:Tetradecanoylphorbol Acetate